A comparative assessment of a-lipoic acid N-phenylamides as non-steroidal androgen receptor antagonists both on and off gold nanoparticles


Autoria(s): Henderson, Luke C.; Altimari, Jarrad M.; Dyson, Gail; Servinis, Linden; Niranjan, Birunthi; Risbridger, Gail P.
Data(s)

01/01/2012

Resumo

A group of α-lipoic acid N-phenylamides were synthesized employing a variety of amide coupling protocols utilizing electron deficient anilines. These compounds were then assessed for their ability to block androgen-stimulated proliferation of a human prostate cancer cell line, LNCaP. These structurally simple compounds displayed anti-proliferative activities at, typically, 5–20 μM concentrations and were comparable to a commonly used anti-androgen Bicalutamide®. The inclusion of a disulfide (RS-SR) moiety, serving as an anchor to several metal nanoparticle systems (Au, Ag, Fe<sub>2</sub>O<sub>3</sub>, etc.), does not impede any biological activity. Conjugation of these compounds to a gold nanoparticle surface resulted in a high degree of cellular toxicity, attributed to the absence of a biocompatible group such as PEG within the organic scaffold.

Identificador

http://hdl.handle.net/10536/DRO/DU:30047076

Idioma(s)

eng

Publicador

Academic Press

Relação

http://dro.deakin.edu.au/eserv/DU:30047076/henderson-comparativeassessment-2012.pdf

http://dx.doi.org/10.1016/j.bioorg.2011.11.007

Direitos

2011, Elsevier

Palavras-Chave #α-Lipoic acid #androgen receptor #bicalutamide #flutamide #prostate cancer
Tipo

Journal Article